BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16368962)

  • 1. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.
    Hashim A; Mulcahy G; Bourke B; Clyne M
    Infect Immun; 2006 Jan; 74(1):99-107. PubMed ID: 16368962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
    Hashim A; Clyne M; Mulcahy G; Akiyoshi D; Chalmers R; Bourke B
    Infect Immun; 2004 Oct; 72(10):6125-31. PubMed ID: 15385517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells.
    Chen XM; LaRusso NF
    Gastroenterology; 2000 Feb; 118(2):368-79. PubMed ID: 10648465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite.
    Edwinson A; Widmer G; McEvoy J
    Int J Parasitol; 2016 Jan; 46(1):67-74. PubMed ID: 26432292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro and ex vivo effect of Auranta 3001 in preventing
    Ch Stratakos A; Sima F; Ward P; Linton M; Kelly C; Pinkerton L; Stef L; Pet I; Iancu T; Pircalabioru G; Corcionivoschi N
    Gut Pathog; 2017; 9():49. PubMed ID: 28883891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with anthroponotic Cryptosporidium parvum does not fully protect the host against a subsequent challenge with C. hominis.
    Sheoran AS; Pina-Mimbela R; Keleher A; Girouard D; Tzipori S
    Microbes Infect; 2018 Apr; 20(4):267-270. PubMed ID: 29357304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting zoonotic transmission of Cryptosporidium in rural New South Wales.
    Ng J; Eastwood K; Durrheim D; Massey P; Walker B; Armson A; Ryan U
    Exp Parasitol; 2008 May; 119(1):192-5. PubMed ID: 18343369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro.
    Bhat N; Joe A; PereiraPerrin M; Ward HD
    J Biol Chem; 2007 Nov; 282(48):34877-87. PubMed ID: 17905738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Imaging of In Vitro
    Anschütz NH; Gerbig S; Ghezellou P; Silva LMR; Vélez JD; Hermosilla CR; Taubert A; Spengler B
    Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627264
    [No Abstract]   [Full Text] [Related]  

  • 10. Bovine TLR2 and TLR4 mediate Cryptosporidium parvum recognition in bovine intestinal epithelial cells.
    Yang Z; Fu Y; Gong P; Zheng J; Liu L; Yu Y; Li J; Li H; Yang J; Zhang X
    Microb Pathog; 2015 Aug; 85():29-34. PubMed ID: 26048276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbation of the intestinal microbiota of mice infected with Cryptosporidium parvum.
    Ras R; Huynh K; Desoky E; Badawy A; Widmer G
    Int J Parasitol; 2015 Jul; 45(8):567-73. PubMed ID: 25913477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum.
    Bushen OY; Kohli A; Pinkerton RC; Dupnik K; Newman RD; Sears CL; Fayer R; Lima AA; Guerrant RL
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):378-84. PubMed ID: 16934303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of Cryptosporidium in humans and cattle in The Netherlands.
    Wielinga PR; de Vries A; van der Goot TH; Mank T; Mars MH; Kortbeek LM; van der Giessen JW
    Int J Parasitol; 2008 Jun; 38(7):809-17. PubMed ID: 18054936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence supporting zoonotic transmission of Cryptosporidium spp. in Wisconsin.
    Feltus DC; Giddings CW; Schneck BL; Monson T; Warshauer D; McEvoy JM
    J Clin Microbiol; 2006 Dec; 44(12):4303-8. PubMed ID: 17005736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomains.
    Nelson JB; O'Hara SP; Small AJ; Tietz PS; Choudhury AK; Pagano RE; Chen XM; LaRusso NF
    Cell Microbiol; 2006 Dec; 8(12):1932-45. PubMed ID: 16848787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoonotic cryptosporidiosis.
    Xiao L; Feng Y
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):309-23. PubMed ID: 18205803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro growth characteristics of Cryptosporidium hominis (IdA15G1) and Cryptosporidium parvum (Iowa-IIaA17G2R1 and IIaA18G3R1).
    Gunasekera S; Clode PL; King B; Monis P; Thierry B; Carr JM; Chopra A; Watson M; O'Dea M; Hijjawi N; Ryan U
    Parasitol Res; 2023 Dec; 122(12):2891-2905. PubMed ID: 37776335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the genetic diversity within Cryptosporidium hominis and Cryptosporidium parvum from imported and autochtonous cases of human cryptosporidiosis by mutation scanning.
    Jex AR; Gasser RB
    Electrophoresis; 2008 Nov; 29(20):4119-29. PubMed ID: 18991263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR slippage across the ML-2 microsatellite of the Cryptosporidium MIC1 locus enables development of a PCR assay capable of distinguishing the zoonotic Cryptosporidium parvum from other human infectious Cryptosporidium species.
    Webber MA; Sari I; Hoefel D; Monis PT; King BJ
    Zoonoses Public Health; 2014 Aug; 61(5):324-37. PubMed ID: 23954136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.